open access

Vol 91, No 2 (2020)
ORIGINAL PAPERS Gynecology
Published online: 2020-02-28
Get Citation

Modified autologous transobturator tape surgery — evaluation of short term results

Alkan Cubuk, Fatih Yanaral, Metin Savun, Ali Ayranci, Akif Erbin, Ozgur Yazici, Mehmet Fatih Akbulut, Omer Sarilar
DOI: 10.5603/GP.2020.0016
·
Pubmed: 32141048
·
Ginekol Pol 2020;91(2):51-56.

open access

Vol 91, No 2 (2020)
ORIGINAL PAPERS Gynecology
Published online: 2020-02-28

Abstract

Objectives: The aim of this study is to evaluate the short-term outcomes of our modified autologous transobturator tape
(aTOT) technique with rectus abdominis muscle fascial graft for the treatment of female stress urinary incontinence (SUI).
Material and methods: The data of 22 patients who underwent modified aTOT were recorded. Perioperative data regarding
operative time, complications and postoperative visual analogue scores were noted. Patients were assessed 18 months
after surgery. The primary endpoints of this study were the improvements in the International Consultation on Incontinence
Questionnaire-Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) subscores, one-hour pad test and cough stress test
rates as an objective cure as well as the improvements in the PGI-I and ICIQ-FLUTS quality of life scores as a subjective cure.
Results: Mean age and the mean follow-up period were 51.7 ± 9.8 years and 20.1 ± 0.9 months, respectively. Urethral
hypermobility and a positive cough stress test were detected in all the patients. Mean operative time was 43.8 ± 8.1 min.
and the overall complication rate was 9%. Mean VAS scores at postoperative 24 hours were 2.6 ± 1.2. At the postoperative
eighteenth month, no patient had a positive cough test and mean PGI-I score was 2 while two patients had moderate
urinary incontinence according to the pad test. Pad test results, ICIQ subscores of voiding QoL, incontinence, incontinence
QoL, total score and total QoL score at baseline and eighteen months after surgery were 76.9 ± 19.9, 9.6 ± 4.1, 15.5 ± 4.0,
39.5 ± 7.9, 27.9 ± 6.6, 68.4 ± 13.8 and 7.1 ± 2, 10.1 ± 2.4, 6.6 ± 2.1, 13.4 ± 4.5, 20.4 ± 4.8, 39.7 ± 9.2 respectively (p = 0.001,
p = 0.004, p = 0.001, p = 0.001, p = 0.001, and p = 0.001, respectively)
Conclusions: Modified aTOT is an effective and safe method with low morbidity for SUI treatment in short term.

Abstract

Objectives: The aim of this study is to evaluate the short-term outcomes of our modified autologous transobturator tape
(aTOT) technique with rectus abdominis muscle fascial graft for the treatment of female stress urinary incontinence (SUI).
Material and methods: The data of 22 patients who underwent modified aTOT were recorded. Perioperative data regarding
operative time, complications and postoperative visual analogue scores were noted. Patients were assessed 18 months
after surgery. The primary endpoints of this study were the improvements in the International Consultation on Incontinence
Questionnaire-Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) subscores, one-hour pad test and cough stress test
rates as an objective cure as well as the improvements in the PGI-I and ICIQ-FLUTS quality of life scores as a subjective cure.
Results: Mean age and the mean follow-up period were 51.7 ± 9.8 years and 20.1 ± 0.9 months, respectively. Urethral
hypermobility and a positive cough stress test were detected in all the patients. Mean operative time was 43.8 ± 8.1 min.
and the overall complication rate was 9%. Mean VAS scores at postoperative 24 hours were 2.6 ± 1.2. At the postoperative
eighteenth month, no patient had a positive cough test and mean PGI-I score was 2 while two patients had moderate
urinary incontinence according to the pad test. Pad test results, ICIQ subscores of voiding QoL, incontinence, incontinence
QoL, total score and total QoL score at baseline and eighteen months after surgery were 76.9 ± 19.9, 9.6 ± 4.1, 15.5 ± 4.0,
39.5 ± 7.9, 27.9 ± 6.6, 68.4 ± 13.8 and 7.1 ± 2, 10.1 ± 2.4, 6.6 ± 2.1, 13.4 ± 4.5, 20.4 ± 4.8, 39.7 ± 9.2 respectively (p = 0.001,
p = 0.004, p = 0.001, p = 0.001, p = 0.001, and p = 0.001, respectively)
Conclusions: Modified aTOT is an effective and safe method with low morbidity for SUI treatment in short term.

Get Citation

Keywords

stress urinary incontinence; mid-urethral sling surgery; mesh; complication

About this article
Title

Modified autologous transobturator tape surgery — evaluation of short term results

Journal

Ginekologia Polska

Issue

Vol 91, No 2 (2020)

Pages

51-56

Published online

2020-02-28

DOI

10.5603/GP.2020.0016

Pubmed

32141048

Bibliographic record

Ginekol Pol 2020;91(2):51-56.

Keywords

stress urinary incontinence
mid-urethral sling surgery
mesh
complication

Authors

Alkan Cubuk
Fatih Yanaral
Metin Savun
Ali Ayranci
Akif Erbin
Ozgur Yazici
Mehmet Fatih Akbulut
Omer Sarilar

References (35)
  1. Linder BJ, Elliott DS. Autologous Transobturator Urethral Sling Placement for Female Stress Urinary Incontinence: Short-term Outcomes. Urology. 2016; 93: 55–59.
  2. Gomes CM, Carvalho FL, Bellucci CH, et al. Update on complications of synthetic suburethral slings. Int Braz J Urol. 2017; 43(5): 822–834.
  3. Linder BJ, El-Nashar SA, Carranza Leon DA, et al. Predictors of vaginal mesh exposure after midurethral sling placement: a case-control study. Int Urogynecol J. 2016; 27(9): 1321–1326.
  4. Chughtai B, Barber MD, Mao J, et al. Association Between the Amount of Vaginal Mesh Used With Mesh Erosions and Repeated Surgery After Repairing Pelvic Organ Prolapse and Stress Urinary Incontinence. JAMA Surg. 2017; 152(3): 257–263.
  5. United States Food and Drug Administration: Considerations about surgical mesh for SUI. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm345219.htm (01.2018).
  6. Chapple CR, Raz S, Brubaker L, et al. Mesh sling in an era of uncertainty: lessons learned and the way forward. Eur Urol. 2013; 64(4): 525–529.
  7. Syan R, Brucker BM. Guideline of guidelines: urinary incontinence. BJU Int. 2016; 117(1): 20–33.
  8. Ghoniem GM, Rizk DEE. Renaissance of the autologous pubovaginal sling. Int Urogynecol J. 2018; 29(2): 177–178.
  9. Bailly GG, Carlson KV. The pubovaginal sling: Reintroducing an old friend. Can Urol Assoc J. 2017; 11(6Suppl2): S147–S151.
  10. Veit-Rubin N, Dubuisson J, Ford A, et al. Burch colposuspension. Neurourol Urodyn. 2019; 38(2): 553–562.
  11. Zacche MM, Mukhopadhyay S, Giarenis I. Changing surgical trends for female stress urinary incontinence in England. Int Urogynecol J. 2019; 30(2): 203–209.
  12. El-Gamal O, Soliman M, Tawfik A, et al. Use of autologous rectus fascia in a new transobturator hybrid sling for treatment of female stress urinary incontinence: a pilot study. Scand J Urol. 2013; 47(1): 57–62.
  13. Osman NI, Hillary CJ, Mangera A, et al. The Midurethral Fascial "Sling on a String": An Alternative to Midurethral Synthetic Tapes in the Era of Mesh Complications. Eur Urol. 2018; 74(2): 191–196.
  14. Walsh LP, Zimmern PE, Pope N, et al. Urinary Incontinence Treatment Network. Comparison of the Q-tip test and voiding cystourethrogram to assess urethral hypermobility among women enrolled in a randomized clinical trial of surgery for stress urinary incontinence. J Urol. 2006; 176(2): 646–649; discussion 650.
  15. D'Ancona C, Haylen B, Oelke M, et al. Standardisation Steering Committee ICS and the ICS Working Group on Terminology for Male Lower Urinary Tract & Pelvic Floor Symptoms and Dysfunction. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019; 38(2): 433–477.
  16. Çubuk A, Erbin A, Savun M, et al. Autologous transobturator midurethral sling. Turk J Urol. 2018; 45(3): 230–232.
  17. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250(2): 187–196.
  18. Fusco F, Abdel-Fattah M, Chapple CR, et al. Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. Eur Urol. 2017; 72(4): 567–591.
  19. Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2015; 7(7): CD006375.
  20. Brubaker L, Richter HE, Norton PA, et al. Urinary Incontinence Treatment Network. 5-year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence. J Urol. 2012; 187(4): 1324–1330.
  21. Albo ME, Richter HE, Brubaker L, et al. Urinary Incontinence Treatment Network. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007; 356(21): 2143–2155.
  22. Palos CC, Maturana AP, Ghersel FR, et al. Prospective and randomized clinical trial comparing transobturator versus retropubic sling in terms of efficacy and safety. Int Urogynecol J. 2018; 29(1): 29–35.
  23. Leone Roberti Maggiore U, Finazzi Agrò E, Soligo M, et al. Long-term outcomes of TOT and TVT procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2017; 28(8): 1119–1130.
  24. Abdel-fattah M, Barrington JW, Youssef M. The standard 1-hour pad test: does it have any value in clinical practice? Eur Urol. 2004; 46(3): 377–380.
  25. Costantini E, Lazzeri M, Bini V, et al. Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence. Urol Int. 2008; 81(2): 153–159.
  26. Urinary incontinence and pelvic organ prolapse in women: management. NICE guidance. https://www.nice.org.uk/guidance/ng123/chapter/Recommendations#assessing-urinary-incontinence.
  27. Urinary Incontinence. European Association of Urology Guidelines 2019. https://uroweb.org/guideline/urinary-incontinence/#3_7.
  28. Fusco F, Abdel-Fattah M, Chapple CR, et al. Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. Eur Urol. 2017; 72(4): 567–591.
  29. Palos CC, Maturana AP, Ghersel FR, et al. Prospective and randomized clinical trial comparing transobturator versus retropubic sling in terms of efficacy and safety. Int Urogynecol J. 2018; 29(1): 29–35.
  30. Blaivas JG, Simma-Chiang V, Gul Z, et al. Surgery for Stress Urinary Incontinence: Autologous Fascial Sling. Urol Clin North Am. 2019; 46(1): 41–52.
  31. Mahdy A, Ghoniem G. Autologous rectus fascia sling for treatment of stress urinary incontinence in women: A review of the literature. Neurourol Urodyn. 2018; 38(S4): 51–58.
  32. Sohlberg EM, Elliott CS. Burch Colposuspension. Urol Clin North Am. 2019; 46(1): 53–59.
  33. Rehman H, Bezerra CCb, Bruschini H, et al. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2011(1): CD001754.
  34. Abraham N, Vasavada S. Urgency after a sling: review of the management. Curr Urol Rep. 2014; 15(4): 400.
  35. Gomes CM, Carvalho FL, Bellucci CH, et al. Update on complications of synthetic suburethral slings. Int Braz J Urol. 2017; 43(5): 822–834.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl